Enliven Therapeutics Inc (ELVN)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Samuel S. Kintz |
Employees: | |
Web site: | www.enliventherapeutics.com |
6200 LOOKOUT ROAD, BOULDER, CO, 80301
720-647-8519
|
Are you looking for these stocks instead?
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Please log in first to see chart